Skip to main content
  • Saved

made a Post

Extrapyramidal Symptoms (EPS)

Extrapyramidal Symptoms (EPS)

Source :

https://www.ncbi.nlm.nih.gov/books/NBK534115/

Extrapyramidal side effects (EPS), commonly referred to as drug-induced movement disorders are among the most common adverse drug effects patients experience from dopamine-receptor blocking agents. It was first described in 1952 after chlorpromazine-induced symptoms resembling Parkinson disease.[1] A variety of movement phenotypes has since been described along the EPS spectrum, including dystonia, akathisia, and parkinsonism, which occur more acutely, as well as more chronic manifestations of tardive akathisia and tardive dyskinesia.